Bristol-Myers Suspends Hepatitis C Treatment Study

Published August 4, 2012

Bristol-Myers suspends hepatitis C treatment study

Filed under: Denver Drug Treatment

The drug, labeled BMS-986094, is one of two main potential hepatitis C treatments from Bristol-Myers that investors are focused on, Bernstein analyst Dr. Tim Anderson said in a research note. The other is a compound labeled daclatasvir that has started …
Read more on Huffington Post

Obesity Medicine Physicians and Bariatric Surgeons Encouraged by FDA …

Filed under: Denver Drug Treatment

DENVER, Jul 17, 2012 (GlobeNewswire via COMTEX) — The American Society of Bariatric Physicians (ASBP) and the American Society for Metabolic and Bariatric Surgery (ASMBS) applaud the Food & Drug Administration (FDA) for approving Qsymia, a new obesity …
Read more on MarketWatch (press release)

Merck's Male Pattern Baldness Drug Propecia Could Cause Sexual Dysfunction …

Filed under: Denver Drug Treatment

Last March, Irwig published a similar type of study where men continued to experience sexual side effects for an average of 40 months after stopping treatment. But the sexual side effects were documented even earlier. According to the U.S. Food and …
Read more on San Francisco Chronicle (press release)

Cancer drug flushes out lurking AIDS virus: study

Filed under: Denver Drug Treatment

(PARIS-AFP) – Scientists in the United States said Wednesday they had used a cancer drug to flush out the AIDS virus lurking dormant in trial patients' white blood cells — a tentative step towards a cure. … Learn what it is, signs, symptoms, and …
Read more on New York Daily News

Gilead Shares Hit Record As Bristol Suspends Study
A setback for Bristol-Myers Squibb Co.'s potential hepatitis C treatment drove shares of rival drug developer Gilead Sciences Inc. to a record high Thursday afternoon. … Read News

Bristol-Myers Squibb Suspends Administration Of Study Drug In Clinical Trial Of Investigational NS5B Nucleotide For …
Bristol-Myers Squibb Company (NYSE: BMY) announced today that the Company has suspended study drug administration in an ongoing Phase II study of BMS-986094 (formerly known as INX-189), a nucleotide polymerase (NS5B) inhibitor in development for the treatment of hepatitis C. … Read News

Bristol-Myers Suspends Hepatitis C Treatment Study
(AP) Drugmaker Bristol-Myers Squibb says it is suspending a mid-stage study of a potential hepatitis C treatment due to a serious patient safety issue. The New York company did not elaborate on … … Read News

October 2011 Epidemics And AIDS Update
Gene variant that helps hepatitis C treatment may hinder HIV treatment MSF Suspends Measles Vaccination Campaign In Mogadishu Area Bristol-Myers, Gilead Work on New Combo HIV Pill 131. Gel Cuts Risk of Herpes Among Women, a Study Finds 132. … Retrieve Document

WORLD NEWS FRIDAY JULY 28th Of 2006:
The news that Bristol-Myers Squibb (nyse: BMY – news – people ) is being investigated by 60,000 people worldwide die from skin cancers caused by too much sun, according to a new study HATHAWAY HELPS WITH HEPATITIS A VACCINATIONS IN NICARAGUA Contactmusic.com – 26 Jul 2006 BROKEBACK … Read Full Source